Clinical Trial Update: A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a peri-CAR-T cell treatment strategy combining polatuzumab vedotin, obinutuzumab, and glofitamab for Large B-cell Lymphoma i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)
• Obinutuzumab (obinutuzumab)
• polatuzumab vedotin (polatuzumab vedotin)

Snippet

Sponsor: University College, London | Conditions: Large B-cell Lymphoma | Phase 2 | Status: RECRUITING